Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: R06AX27

Desloratadine Teva(desloratadine)

Rhinitis, Allergic, Perennial;Rhinitis, Allergic, Seasonal

Marketing Authorisation Holder: Teva B.V

EMA Authorisation: 24/11/2011

INN: desloratadine

Indication

Desloratadine Teva is indicated for the relief of symptoms associated with: allergic rhinitis; urticaria.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Desloratadine Teva — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.